How do we make progress in phenotyping patients with lower urinary tract such as overactive bladder and underactive detrusor, including using urine markers and microbiome data, to personalize therapy? ICI-RS 2023-Part 2

Affiliations

• ¹ Department of Surgical Sciences, University of Rome Tor Vergata and Urology Unit, Policlinico Tor Vergata University Hospital, Rome, Italy.
• ² School of Specialization in Urology, University of Rome Tor Vergata and Urology Unit, Policlinico Tor Vergata University Hospital, Rome, Italy.
• ³ Department of Medicine, University of Alberta, Edmonton, Alberta, Canada.
• ⁴ Department of Urology, Apollo Hospital, Hyderabad, India.
• ⁵ Department of Urology, University Hospital Monklands, NHS Lanarkshire, Airdrie, UK.
• ⁶ Department Obstetrics and Gynecology. Urogynecology Unit, University of Insubria, Varese, Italy.
• ⁷ Urinary Incontinence Center, Urology and Renal Transplantation Unit, Policlinico di Foggia Hospital and University of Foggia, Foggia, Italy.
• ⁸ Department of Urology, School for Mental Health and Neuroscience, Faculty of Health, Medicine and Life Sciences, Maastricht University Medical Center, Maastricht University, Maastricht, The Netherlands.
• ⁹ Marmara University School of Medicine, Istanbul, Turkey.
• ¹⁰ Koç University, Istanbul, Turkey.
• ¹¹ Desai Sethi Institute of Urology, Miller School of Medicine, University of Miami, Miami, Florida, USA.
• ¹² Department of Urology, University of Bristol, Bristol, UK.
• ¹³ Gent University Hospital, Gent, Belgium.